More than a dozen faculty members from the Department of Psychiatry at the University of Rochester School of Medicine and Dentistry will direct programs, conduct research and provide treatment at the new Veterans Administration Center of Excellence in Canandaigua.
An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.
A team of Mayo Clinic researchers has discovered a new, more accurate diagnostic test to detect infection of prosthetic joints, potentially leading to better treatment options and patient outcomes.
Health Canada is currently requesting and reviewing new safety information regarding serious liver adverse events in patients using Prexige (lumiracoxib), a Cox-2 inhibitor non-steroidal anti-inflammatory drug (NSAID). Prexige is used in the treatment of osteoarthritis (OA) in adults.
Australia is experiencing a worse than normal influenza season in 2007, with increased numbers of cases being reported across several states and territories.
A report commissioned to develop a research methodology to study the health of children of Vietnam veterans has been released by the Minister of Veterans? Affairs, Bruce Billson.
The U.S. Food and Drug Administration announced the approval of updated labeling for the widely used blood-thinning drug, Coumadin, to explain that people’s genetic makeup may influence how they respond to the drug.
Researchers in Taiwan have demonstrated for the first time that urban air pollution simultaneously affects key indicators of cardiovascular risk in young adults: inflammation, oxidative stress, coagulation and autonomic dysfunction.
Children who are chronically exposed to higher levels of air pollution show marked deficiencies in lung growth and function, and not just short-term breathing problems, according to researchers in Mexico.
Prescribing ambulatory oxygen in patients with chronic obstructive pulmonary disease improves exercise performance, but not the quality of their daily life unless they have resting hypoxemia, according to researchers in Toronto.